<DOC>
	<DOCNO>NCT01527864</DOCNO>
	<brief_summary>A phase II , multicenter , randomize , double-blind , placebo-controlled study carry . Patients randomly assign treatment ( PC + pegylated endostatin ) control group ( PC+ placebo ) . The efficacy evaluate every six weeks.Follow-up continued disease progression death .</brief_summary>
	<brief_title>Paclitaxel-Carboplatin Alone With M2ES Non-Small-Cell Lung Cancer</brief_title>
	<detailed_description>A randomized phase 2 study , involve patient advance non-small-cell lung cancer previously receive chemotherapy , compare paclitaxel carboplatin Plus placebo paclitaxel carboplatin plus PEGylated endostatin , PEGylated endostatin dose 10 mg/m2 intravenously every week .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Endostatins</mesh_term>
	<criteria>1 . Histologically cytologically confirm , newly diagnose stage IIIB stage IV cancer recurrent nonsmallcell lung cancer receive chemotherapy , target therapy . 2 . Prior radiation therapy allow provide site disease locate lung . 3 . Measurable disease define Response Evaluation Criteria Solid Tumors ( RECIST ) . 4 . ≥18 year age . 5 . ECOG performance status 0 1 . 6 . Life expectancy least 12 week . 7 . Adequate hematologic , hepatic , renal function . 8 . Patients voluntary participate sigh inform content . 1 . Major surgery within prior 4 week . 2 . Participating clinical trial within prior 4 week . 3 . Patients clinically apparent CNS disease ( primary brain tumor , tumor relate apoplexy , CNS metastases , carcinomatous meningitis . ) 4 . Another active malignancy , history malignancy within past 3 year except nonmelanoma skin cancer carcinoma situ cervix . 5 . Pregnant lactating woman . 6 . Radiation therapy complete 4 week enrollment . 7 . Pulmonary embolus , deep venous thrombosis bleed diathesis . 8 . Uncontrolled intercurrent illness following : prior ongoing uncontrolled hypertension ; angina pectoris ; congestive cardiac failure ; myocardial ischemia , infarction , uncompensated coronary artery disease within past 12 month ; Uncontrolled arrhythmia ; Uncontrolled diabetes mellitus ; Uncontrolled infection . 9 . Grade 2 hemoptysis within past 6 month . 10 . Acute chronic renal disease . 11 . Active hepatitis HIV . 12 . ECG : QTC ≥ 480 ms. 13 . Patients therapeutic dos heparin . 14 . Other condition regard exclusion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>NSCLC</keyword>
</DOC>